|
|
News Breaks
|
November 4, 2009
|
| 08:52 EDT |  | ITMN |
| theflyonthewall.com: | Intermune submits Pirfenidone NDA to FDA | | InterMune has submitted an electronic New Drug Application with the FDA seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis. Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe. :theflyonthewall.com |
|
|
News For ITMN From The Last 14 Days Check below for free stories on ITMN the last two weeks.
There are 4 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 9, 2012
|
| 16:27 EDT |  | ITMN |
| theflyonthewall.com: | Leerink's biotech and pharmaceuticals analysts hold a conference call | | Biotech Analysts Schimmer and Liang, along with Pharmaceuticals Analyst Fernandez, review the reimbursement process for drugs in France on an Analyst/Industry conference call. Relevant covered companies ACOR, AMGN, AMLN, AUXL, BIIB, BMY, GILD, HGSI, ITMN, JNJ, NVS, PFE and VRTX may be included on the Analyst/Industry conference call to be held on February 10 at 11 am. :theflyonthewall.com |
| | 16:09 EDT |  | ITMN |
|
|
January 31, 2012
|
| 10:09 EDT |  | ITMN |
| | 09:55 EDT |  | ITMN |
|
|
|
|
|
Subscribe for More Information